As forecasted by XploreMR in a recent market study, the global organoids market is on a positive growth trajectory during the forecast period (2019 - 2029). An organoid is a simplified and smaller version of an organ that represents the micro-anatomy of the specific organ. Constituted of stem cells, tissues, or pluripotent stem cells, organoids can organize themselves in three-dimensions, thus allowing scientists to study the behavior of cells, and test new medicines for diseases such as Alzheimer's, which is not completely understood by scientists. The market is receiving a significant boost from advancements in 3D printing technologies, which are enabling the development of complex organoids. Likewise, Big Data technology is enabling scientists to study human cells.
High Adoption in Drug Discovery and Testing Bolsters Market Growth
Rising incidence of several infections and other bacteria-borne diseases around the globe is raising the need for efficient medications that utilize biotechnology through genetic manipulation of living cells or organisms. Organoids and 3D cell culture bolster scientists to accomplish this. The recent developments in human developmental biology, coupled with the organoids, have allowed scientists and researchers to recreate morphogenetic processes that take place during the formation of organs and tissue in the human body. Since organoids are capable of replicating the complexity and structure of human organs and tissues, their adoption in drug discovery and testing applications has risen over the years. Organoids also help in investigating various complex diseases and predict the efficiency of a new drug. Furthermore, organoids eliminate the need for preclinical testing, thereby lowering the cost and saving time to discover drugs.
North America to Dominate Regional Landscape of Organoids Market
North American region will dominate the regional landscape organoids market on the back of rising technological adoption of Big Data, and effective processing by the Food and Drug Administration (FDA). Likewise, high innovation in the industry is acting as a catalyst to the market growth. Following North America is the Asia Pacific, which is growing at a significant rate owing to high private investments for research in the pharmaceutical industry, and similar effective approval process by the Chinese FDA.
Impact of COVID-19 Global Organoid Market
The outbreak of COVID-19 is expected to have a positive impact on market growth. With various organizations racing to develop a vaccine, researchers are studying the use of organoids to treat the patients. Organoids of respiratory systems are likely to gain traction on the back of this factor. On this premise, the Biotechnology Industry Research Assistance Council (BIRAC) has announced funding to OncoSeek, an Indian start-up, to develop a potential cure for the COVID-19 virus. The startup will be developing an in vitro lung organoids, which are a 3D tissue-engineering mini lung with an ability to replicate tissues of the human lungs.
Founder and CEO of OncoSeek Bio Suresh Poosala quoted: “The company envisages creating a novel in vitro platforms for Covid-19 research under the support,”
Akin to OncoSeek, numerous other organizations are expected to receive government and private investments in the near term.